Radiation Exposure in Intraoperative Cholangiography

Status Completed

Clinical Trial Summary

Aims: to determine the radiation exposure of routine intraoperative cholangiography (IOC )during cholecystectomy and examine the factors affecting radiation dose and fluoroscopy time (FT).

Methods: 598 intraoperative cholangiography examinations were performed at the Central Finland Central Hospital. In this study we included 324 intraoperative cholangiographies performed with c-arm equipment not exceeding 10 years of age.

Clinical Trial Description

From January 2016 to December 2017, consecutive 598 intraoperative cholangiography examinations were performed at the Central Finland Central Hospital. In this study we included 353 cholangiographies, that were performed with our c-arm equipment not exceeding 10 years of age in the beginning of 2016. The main measures of outcome were the recorded radiation dose data of c-arm systems from our manual database .

Another 25 cases were excluded because it was not possible to cross-check the manually recorded radiation dose data from the Picture Archiving and Communication System (PACS ). Additional 4 patients who underwent intraoperative endoscopic retrograde cholangiopancreatography (ERCP) were removed from the radiation exposure analysis because IOC and ERCP were performed consequently with the same c-arm and the radiation exposure of IOC could not be separated from the registered total KAP and FT. Thus the final analysis consisted of 324 IOCs. KAP (Kerma area product) is the product of air Kerma in the center of the imaging area multiplied with size of the imaging area. For simplicity we have unified varying units received from different c-arms and will only use Gray multiplied by square centimeters (Gycm2 ). KAP values were measured using inbuilt ionization chambers in c-arms. For this study we collected the KAP values from exposure and pulsed fluoroscopy. We also recorded the fluoroscopy time (s).

Laparoscopic cholecystectomies were performed both by residents and specialist surgeons.

Ethics: No ethical approval or written informed consent were needed because the study was retrospective in nature. The study was approved by the hospital administration. ;

Study Design

Related Conditions & MeSH terms

Radiation Exposure

Clinical Trial Details

NCT number	NCT03817723
Study type	Observational
Source	Jyväskylä Central Hospital
Contact
Status	Completed
Phase
Start date	January 1, 2016
Completion date	September 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03649451` - Reference Dose Levels During Fluoroscopically Guided Procedures in Operating Rooms
Completed	`NCT03305978` - Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan.	N/A
Recruiting	`NCT04139096` - Genetic Susceptibility to Radiation Induced Thyroid Cancer
Completed	`NCT01430975` - Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites	N/A
Completed	`NCT01424774` - Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning	N/A
Completed	`NCT00378053` - A Prospective Study of Radiation Exposure to Surgeons	N/A
Recruiting	`NCT05561439` - Individual Dosimetric Monitoring of Workers During Interventional Radiology and Cardiology Procedures for Cardiologists and Radiologists in France
Completed	`NCT04078165` - Suspended Personal Protection System Versus Conventional Protection (Aka Zero-Gravity vs Shield and Apron)	N/A
Recruiting	`NCT04694391` - Genomic Study of Relapse Esophageal Cancer After Radiotherapy
Not yet recruiting	`NCT04403815` - Radiation Exposure During Coronary Procedures According to Vascular Access
Recruiting	`NCT04285944` - Operator Radiation Protection During Cardiac Catheterization Using Mavig X-ray Protective Drapes®.	N/A
Completed	`NCT04363190` - Genomic Instability in Vascular Surgeons
Completed	`NCT04404257` - Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation	N/A
Recruiting	`NCT04678258` - Zero Fluoroscopy Voltage Guided vs. Linear CTI Ablation	N/A
Recruiting	`NCT03386500` - Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer	Phase 1/Phase 2
Recruiting	`NCT05833516` - Hyper Adduction of Right Radial Artery/Arm vs Left Drag Over Technique
Recruiting	`NCT03946280` - Utility of 3D Navigation to Reduce Ionizing Radiation in Common Flutter Ablation. Study of Personnel and Patient Dosimetry	N/A
Completed	`NCT03985488` - Radiation Exposure Assessment in Fluoroscopy
Completed	`NCT03605030` - Reducing Radiation Exposure to Operators During Invasive Cardiac Procedures	N/A
Recruiting	`NCT02689908` - Individualized Radiation Dose Control	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.